Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ethambutol 375mg/5ml oral solution
0501090H0AAATAT
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 400mg/5ml oral liquid
0501090H0AAASAS
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 450mg/5ml oral solution
0501090H0AABBBB
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 500mg/5ml oral liquid
0501090H0AAARAR
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 50mg/5ml oral solution
0501090H0AABGBG
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 600mg/5ml oral liquid
0501090H0AAAXAX
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 700mg/5ml oral solution
0501090H0AABEBE
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethambutol 700mg/5ml oral suspension
0501090H0AABIBI
|
Ethambutol hydrochloride | Ethambutol hydrochloride | Infections | No data available |
|
Ethionamide 250mg tablets
0501090I0AAAAAA
|
Ethionamide | Ethionamide | Infections | No data available |
|
Etravirine 100mg tablets
0503010AFAAAAAA
|
Etravirine | Etravirine | Infections | No data available |
|
Etravirine 200mg tablets
0503010AFAAABAB
|
Etravirine | Etravirine | Infections | No data available |
|
Etravirine 25mg tablets
0503010AFAAACAC
|
Etravirine | Etravirine | Infections | No data available |
|
Eurartesim 320mg/40mg tablets
0504010ABBBAAAA
|
Eurartesim | Piperaquine phosphate/artenimol | Infections | No data available |
|
Eviplera 200mg/25mg/245mg tablets
050301000BBABA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | No data available |
|
Evotaz 300mg/150mg tablets
0503010ALBBAAAA
|
Evotaz | Atazanavir and cobicistat | Infections | No data available |
|
Evoxil 250mg tablets
0501120X0BCAAAB
|
Evoxil | Levofloxacin | Infections | No data available |
|
Evoxil 500mg tablets
0501120X0BCACAA
|
Evoxil | Levofloxacin | Infections | No data available |
|
Evoxil 500mg/100ml solution for infusion vials
0501120X0BCABAC
|
Evoxil | Levofloxacin | Infections | No data available |
|
Exblifep 2g/0.5g pdr for concentrate for inf vials
0501024A0BBAAAA
|
Exblifep | Cefepime/Enmetazobactam | Infections | No data available |
|
Exviera 250mg tablets
0503032H0BBAAAA
|
Exviera | Dasabuvir | Infections | No data available |
|
Famciclovir 750mg tablets
0503021E0AAACAC
|
Famciclovir | Famciclovir | Infections | No data available |
|
Famvir 750mg tablets
0503021E0BBACAC
|
Famvir | Famciclovir | Infections | No data available |
|
Fansidar tablets
0504010P0BBAAAA
|
Fansidar | Pyrimethamine with sulfadoxine | Infections | No data available |
|
Fasigyn 500mg tablets
0501110G0BBAAAB
|
Fasigyn | Tinidazole | Infections | No data available |
|
Febzin XL 500mg tablets
0501050B0BGAAAE
|
Febzin | Clarithromycin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.